GABAA Rρ2 Activators

GABAA Rρ2 Activators, through distinct but converging pathways, potentiate the inhibitory signaling crucial for maintaining the balance of neural excitability. The general anesthetics etomidate and propofol, for instance, target specific sites on the GABAA Rρ2, enhancing the receptor's activity by increasing the duration of channel opening in response to GABA. This action directly contributes to the anesthetic properties of these compounds by strengthening inhibitory neurotransmission. Barbiturates like Phenobarbital similarly extend the open state of the GABAA Rρ2 channel, leading to a sustained inhibitory effect. Flumazenil, although primarily a benzodiazepine antagonist, can exert a modulatory effect on GABAA Rρ2 activity, potentially by causing a compensatory increase in receptor sensitivity.

Zinc, at low concentrations, acts as a positive allosteric modulator, while picrotoxin, a channel blocker, can indirectly evoke an increase in GABAA Rρ2 activity as part of a homeostatic response to enhanced excitability. Neurosteroids such as 5α-Tetrahydrodeoxycorticosterone and isopregnanolone modulate the receptor's function by varying the channel opening frequency, either enhancing or indirectly promoting GABAA Rρ2 mediated inhibition. Taurine directly activates GABAA Rρ2, serving as an agonist that promotes inhibitory neurotransmission. In contrast, bicuculline, a receptor antagonist, indirectly promotes upregulation and increased GABA sensitivity of GABAA Rρ2, highlighting the receptor's adaptability and integral role in the inhibitory signaling pathways. Collectively, these activators function through nuanced modulation of the GABAA Rρ2, reinforcing its pivotal role in mediating inhibitory synaptic transmission without necessitating changes in receptor expression.